← Back to all trials
Recruiting
NCT05766839
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
Conditions: Hyperkalemia
Sex: All
Ages: 0 Years – 11 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 32
Sponsor: Vifor Pharma, Inc.
Location: Children's Hospital Colorado Aurora Colorado
Summary
A study to evaluate the pharmacodynamic effects, safety, and tolerability of patiromer in children under 12 years of age with hyperkalaemia.
Eligibility Criteria
Inclusion Criteria:
* Paediatric participants (\
Source: ClinicalTrials.gov (NCT05766839). StuddyBuddy aggregates publicly available trial information.
